Cancer is the second-leading cause of death in the United States, accounting for over 613,000 fatalities in 2023, per the Centers for Disease Control. But the field of cancer vaccines, which can be ...
Advances are reshaping treatment for small cell lung cancer, with immunotherapy and emerging options offering hope for longer survival and potential cures. Immunotherapy is changing treatment ...
The PA Breast Cancer Coalition has awarded two Thomas Jefferson University researchers with $100,000 dollar grants to advance groundbreaking work in triple-negative breast cancer and immunotherapy.
Circulating tumor DNA levels a few weeks after immunotherapy initiation could help identify patients with melanoma at greatest risk for recurrence or death.A retrospective analysis showed individuals ...
Aug. 4 (UPI) --Findings from a study in mice suggest that using a common artificial sweetener, sucralose, could hamper certain immunotherapy treatments in cancer patients. However, for folks reluctant ...
The combination of belzutifan plus lenvatinib significantly improved outcomes for patients with clear cell renal cell carcinoma who progressed following immunotherapy compared with cabozantinib ...
A new nanovaccine—a type of vaccine that uses tiny particles for a more targeted delivery to the immune system—could offer a “dual blow” against cancer. This is the finding of researchers from the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results